Biomerica, Inc. – NASDAQ:BMRA

Biomerica stock price today

$2.85
+2.53
+803.61%
Financial Health
0
1
2
3
4
5
6
7
8
9

Biomerica stock price monthly change

-11.74%
month

Biomerica stock price quarterly change

-11.74%
quarter

Biomerica stock price yearly change

-73.75%
year

Biomerica key metrics

Market Cap
4.55M
Enterprise value
21.34M
P/E
-4.35
EV/Sales
1.32
EV/EBITDA
-4.30
Price/Sales
1.56
Price/Book
3.47
PEG ratio
-0.13
EPS
-0.48
Revenue
8.53M
EBITDA
-6.65M
Income
-7.11M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-34.58%
Oper. margin
-34.82%
Gross margin
16.11%
EBIT margin
-34.82%
EBITDA margin
-77.89%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Biomerica stock price history

Biomerica stock forecast

Biomerica financial statements

Biomerica, Inc. (NASDAQ:BMRA): Profit margin
May 2022 5.30M -1.75M -33.18%
Feb 2023 1.11M -1.64M -148.44%
May 2023 1.10M -1.79M -161.72%
Feb 2024 1.01M -1.91M -188.59%
Biomerica, Inc. (NASDAQ:BMRA): Debt to assets
Nov 2022 9907547 2.66M 26.9%
Feb 2023 8210168 2.22M 27.09%
May 2023 14454000 2.73M 18.89%
Feb 2024 10342000 2.53M 24.5%
Biomerica, Inc. (NASDAQ:BMRA): Cash Flow
May 2022 -4.25M -24.35K 38.18K
Feb 2023 -1.72M -5.76K 24.75K
May 2023 -962.67K -14.14K 7.34M
Feb 2024 -1.80M -16K 0

Biomerica alternative data

Biomerica, Inc. (NASDAQ:BMRA): Employee count
Aug 2023 64
Sep 2023 62
Oct 2023 62
Nov 2023 62
Dec 2023 62
Jan 2024 62
Feb 2024 62
Mar 2024 62
Apr 2024 62
May 2024 62
Jun 2024 62
Jul 2024 62

Biomerica other data

13.05% -12.84%
of BMRA is owned by hedge funds
1.75M -1.72M
shares is hold by hedge funds

Biomerica, Inc. (NASDAQ:BMRA): Insider trades (number of shares)
Period Buy Sel
Jan 2023 7528 0
Apr 2023 11400 0
May 2023 4200 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
IRANI ZACKARY S. director, officer: Chief Execut..
Common Stock 200 $1.55 $310
Purchase
IRANI ZACKARY S. director, officer: Chief Execut..
Common Stock 500 $1.61 $805
Purchase
IRANI ZACKARY S. director, officer: Chief Execut..
Common Stock 1,700 $1.17 $1,989
Purchase
IRANI ZACKARY S. director, officer: Chief Execut..
Common Stock 500 $1.27 $635
Purchase
IRANI ZACKARY S. director, officer: Chief Execut..
Common Stock 300 $1.39 $417
Purchase
IRANI ZACKARY S. director, officer: Chief Execut..
Common Stock 1,000 $1.36 $1,360
Purchase
IRANI ZACKARY S. director, officer: Chief Execut..
Common Stock 1,800 $1.34 $2,412
Purchase
IRANI ZACKARY S. director, officer: Chief Execut..
Common Stock 2,600 $1.31 $3,406
Purchase
IRANI ZACKARY S. director, officer: Chief Execut..
Common Stock 7,000 $1.26 $8,820
Purchase
BARBIERI ALLEN officer: Executiv.. Common Stock 1,538 $2.94 $4,522
Patent
Application
Filling date: 21 Aug 2020 Issue date: 10 Jun 2021
Application
Filling date: 14 Jun 2019 Issue date: 2 Jan 2020
Application
Filling date: 16 Apr 2019 Issue date: 8 Aug 2019
Application
Filling date: 8 Jan 2019 Issue date: 8 Aug 2019
Application
Filling date: 12 Dec 2018 Issue date: 8 Aug 2019
Thursday, 21 November 2024
globenewswire.com
Thursday, 7 November 2024
globenewswire.com
Wednesday, 30 October 2024
globenewswire.com
Wednesday, 16 October 2024
globenewswire.com
Wednesday, 4 September 2024
globenewswire.com
Thursday, 29 August 2024
globenewswire.com
Monday, 1 July 2024
globenewswire.com
Monday, 13 May 2024
globenewswire.com
Monday, 29 April 2024
globenewswire.com
Monday, 15 April 2024
globenewswire.com
Friday, 12 April 2024
globenewswire.com
Thursday, 28 March 2024
globenewswire.com
Wednesday, 21 February 2024
globenewswire.com
Tuesday, 23 January 2024
globenewswire.com
Tuesday, 16 January 2024
globenewswire.com
Monday, 18 December 2023
globenewswire.com
Friday, 10 November 2023
globenewswire.com
Wednesday, 8 November 2023
globenewswire.com
Friday, 13 October 2023
globenewswire.com
globenewswire.com
Tuesday, 26 September 2023
globenewswire.com
Monday, 28 August 2023
globenewswire.com
Friday, 25 August 2023
globenewswire.com
Thursday, 3 August 2023
globenewswire.com
Friday, 14 October 2022
Market Watch
Thursday, 14 July 2022
Benzinga
Tuesday, 19 October 2021
Benzinga
GlobeNewsWire
Friday, 15 October 2021
GlobeNewsWire
Tuesday, 5 October 2021
Pulse2
  • What's the price of Biomerica stock today?

    One share of Biomerica stock can currently be purchased for approximately $2.85.

  • When is Biomerica's next earnings date?

    Biomerica, Inc. is estimated to report earnings on Tuesday, 26 Aug 2025.

  • Does Biomerica pay dividends?

    No, Biomerica does not pay dividends.

  • How much money does Biomerica make?

    Biomerica has a market capitalization of 4.55M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1.42% to 5.42M US dollars.

  • What is Biomerica's stock symbol?

    Biomerica, Inc. is traded on the NASDAQ under the ticker symbol "BMRA".

  • What is Biomerica's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Biomerica?

    Shares of Biomerica can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Biomerica's key executives?

    Biomerica's management team includes the following people:

    • Mr. Steven Sloan Chief Financial Officer & Treasurer(age: 55, pay: $166,670)
    • Mr. Zackary S. Irani Chairman & Chief Executive Officer(age: 59, pay: $136,610)
    • Mr. Allen C. Barbieri Executive Vice-Chairman & Corporation Sec.(age: 67, pay: $90,000)
  • How many employees does Biomerica have?

    As Jul 2024, Biomerica employs 62 workers.

  • When Biomerica went public?

    Biomerica, Inc. is publicly traded company for more then 40 years since IPO on 7 Sep 1984.

  • What is Biomerica's official website?

    The official website for Biomerica is biomerica.com.

  • Where are Biomerica's headquarters?

    Biomerica is headquartered at 17571 Von Karman Avenue, Irvine, CA.

  • How can i contact Biomerica?

    Biomerica's mailing address is 17571 Von Karman Avenue, Irvine, CA and company can be reached via phone at +94 96452111.

Biomerica company profile:

Biomerica, Inc.

biomerica.com
Exchange:

NASDAQ

Full time employees:

64

Industry:

Medical - Devices

Sector:

Healthcare

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, diabetes, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods, an irritable bowel syndrome therapy technology and diagnostic-guided therapy; Helicobacter pylori products, as well as develops, tests, validates, and sells diagnostic products for COVID-19 infection. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.

17571 Von Karman Avenue
Irvine, CA 92614

CIK: 0000073290
ISIN: US09061H3075
CUSIP: 09061H307